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C/EBPc Regulates Wound Repair and EGF Receptor
Signaling
Roberta Melchionna1,2, Gabriella Bellavia1,2, Marta Romani1, Stefania Straino1, Antonia Germani1,
Anna Di Carlo1, Maurizio C. Capogrossi1 and Monica Napolitano1
We aimed at identifying novel regulators of skin wound healing (WH), in an epidermal scratch WH assay, by a
small interfering RNA (siRNA) silencing approach. Several transcription factors have been previously reported
to affect wound repair. We here show that gene silencing of the transcription factor CAAT enhancer–binding
protein g (C/EBPg), STAT3, REL, RELA, RELB, SP1, and NFkB impaired WH in vitro, in keratinocytes, whereas E2F
and CREBBP silencing accelerated the WH process. We further characterized C/EBPg, as its silencing yielded the
maximal impairment (52.2±12.5%) of scratch wounding (SW). We found that C/EBPg silencing inhibited both
EGF- and serum-induced keratinocyte migration, whereas C/EBPg overexpression enhanced cell migration to
EGF and to serum via the EGFR. Further, C/EBPg silencing impaired scratch-induced Y1068 and Y1173 EGFR
phosphorylation, as well as Y118 paxillin phosphorylation, key molecules regulating cell migration and
epidermal WH. Moreover, C/EBPg levels were induced in keratinocytes, following both SW and EGF stimulation.
C/EBPg siRNA silencing in vivo impaired WH at 3, 5, 7, and 14 days following excisional wounding in mice
inhibited both re-epithelialization and granulation tissue formation, and induced a decrease of arteriole
number. In conclusion, we here report that C/EBPg positively regulates wound repair both in vitro and in vivo, at
least in part, by affecting EGFR signaling.
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INTRODUCTION
Epidermal wound healing (WH) is a complex physiological
process involving keratinocyte proliferation, migration, and
differentiation at the wound edge (Clark, 1993).
Healing impairment in chronic wounds can be caused by
several local factors, including ischemia, foreign bodies,
tissue maceration, and infection, as well as by systemic
factors such as diabetes, aging, malnutrition, and renal
disease. Decreased growth factor expression/function, angio-
genesis, keratinocyte, fibroblast, and macrophage function
are among the factors responsible for delayed WH in diabetes
(Brem and Tomic-Canic, 2007).
Current therapies for chronic ulcer treatment include
debridement, topical antibiotics, hyperbaric oxygen, electrical
stimulation, exogenous growth factors, and bioengineered skin
substitutes, such as collagen matrices and neonatal fibroblasts
or dermal fibroblasts and Dermagraf (Hinchliffe et al., 2008;
Cavanagh and Bus, 2010).
As WH impairment represents a major health problem, the
molecular events required for adequate healing constitute a
major research focus.
A number of transcription factors, including c-jun, ATF3,
EGR1, JUN, JUNB, FOS, GATA3, and ETS1, have been found
to be modulated upon scratching and to be crucial for wound
repair (Angel et al., 2001; Li et al., 2003).
Gene silencing by small interfering RNAs (siRNAs) is a
useful approach for isolating molecules involved in specific
biological processes. Recently, such technique has been used
to pinpoint genes involved in breast cancer metastasis
(Simpson et al., 2008).
The aim of our project was to identify, by a small-scale
siRNA approach, transcription factors that, when silenced,
either accelerated or impaired keratinocyte migration in vitro
and skin wound repair in vivo, which can possibly set the basis
for new therapies of chronic ulcer healing. Mechanical
scratching has been used, for the screening, as an in vitro assay
to mimic aspects of the re-epithelialization process. We focused
our study on the transcription factor CAAT enhancer–binding
protein (C/EBP)g and characterized its role in wound repair.
RESULTS
Identification of genes modulating skin WH
To screen for genes that would accelerate or impair
skin wound closure, we silenced 42 transcription factors
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(Suresilencing, SABiosciences, Valencia, CA) in the scratch
wound assay, adapted to 96-well plates. Briefly, a monolayer
of keratinocytes, i.e., the cell line HaCaT, was transfected
with single siRNAs that silence specific transcription factors
and, at 24 hours, subjected to wounding by a linear scratch
with a yellow tip. The area denuded of cells at the time of the
scratch (t0) and at 24 hours (t24) post wounding was
measured by the Image J program to determine the ratio of
the area of t24 by t0, in each well, in which individual genes
were silenced (Figure 1a). Data were then expressed as fold
wound closure relative to CTRL siRNA present in each plate.
Overall, the vast majority of the 42 silenced transcription
factors, i.e., 78.6%, had no effect on WH; 4.8% of the genes
accelerated WH, whereas 16.6% impaired wound closure
(Figure 1b, left panel). In particular, silencing C/EBPg, STAT3,
REL, RELA, RELB, SP1, and NFkB impaired WH compared
with control-silenced cells (Po0.05), whereas transfection of
siRNAs for CREBBP and E2F1 accelerated in vitro wound
closure (Po0.05; Figure 1b, right panel). The results represent
the mean of four independent experiments±SD. We next
carried out the validation of two of the identified genes, i.e.,
C/EBPg and NFkB, by silencing them by short hairpin RNA
(shRNA) lentiviral expression (Sigma) in order to exclude, by
an independent method, whether off-target effects, related to
specific sequence silencing, were at play in the primary
screen; we therefore analyzed the messenger RNA (mRNA)
expression levels by quantitative real-time reverse-transcrip-
tase–PCR to assess gene silencing (Figure 1c and d) and
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Figure 1. Identification of transcription factors regulating in vitro wound healing by a small interfering RNA (siRNA) silencing approach. (a) Screening:
representative picture of scratch-wounded (t24) HaCaT cells transfected with a control siRNA (left panel), one of the siRNAs that impaired wound closure
(middle panel, and Figure 1b right panel), and an siRNA that accelerated wound closure. Bar¼300 mm. (b) Left panel: the circle shows the percentage of
transcription factors, among the 42 genes that were tested, whose silencing had no effect (78.6%), impaired (16.6%), or accelerated (4.8%) in vitro wound
closure in HaCaT cells. Right panel: shown is a histogram indicating fold wound closure, relative to CTRL (Po0.05), of the transcription factors identified in the
screening as modulators of in vitro wound healing, as an average of four independent experiments. White column: siRNA control; gray columns: transcription
factors whose silencing impaired wound healing; black columns: transcription factors whose silencing accelerated wound healing. Stable cell lines of (c) shC/
EBPg and (d) shNFkB were validated for gene silencing by quantitative real-time reverse-transcriptase–PCR (qRT-PCR), and subjected to the scratch wound assay
in e and f, respectively. (c–f) *Po0.05 versus shCTRL.
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confirmed the functional effect of C/EBPg and NFkB silencing
in the scratch WH assay (Figure 1e and f).
Interestingly, NFkB, REL, RELA, and RELB (NFKB family
members) silencing impaired wound closure. In keeping with
previous results, STAT3 had a positive role in wound repair
(Sano et al., 1999).
We focused our studies on C/EBPg, as its silencing yielded
the maximal impairment of scratch wounding (SW) among all
factors tested (52.2±12.5%), thus suggesting that the activity
of such gene promotes wound closure.
C/EBPc expression is induced in keratinocytes upon
in vitro wounding
We then investigated whether C/EBPg expression may be
modulated upon wounding. Scratch wounding of keratino-
cyte monolayer was performed and C/EBPg mRNA expres-
sion was analyzed at 3, 6, 16, and 24 hours post wounding.
We found an increase of C/EBPg expression at all time points,
versus t0 (Figure 2a). Further, C/EBPg protein levels increased
at 24 hours post wounding, as assessed by western blotting
(Figure 2b, upper and lower panel). The expression levels of
other C/EBP family members, i.e., C/EBPa and C/EBPb, were
analyzed following SW. C/EBPa mRNA increased at 24 hours
post SW, whereas protein expression levels were not affected
by linear scratch (Figure 2c and d, respectively). C/EBPb
mRNA was instead barely detectable both at baseline and
post wounding (not shown).
C/EBPc promotes cell migration to EGF, and to serum via EGFR
The cellular response to scratch wound involves cell
migration and proliferation. To address the role of C/EBPg
in both processes, shRNA C/EBPg-silenced HaCaT cells were
first tested for their ability to migrate to either EGF, as this
molecule is a crucial factor in WH and has a key role in
cell migration (Wilson et al., 1999), or to 20% fetal bovine
serum (FBS). In these experiments, C/EBPg expression was
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Figure 2. CAAT enhancer–binding protein c (C/EBPc) is induced in keratinocytes upon in vitro wounding. (a) C/EBPg messenger RNA (mRNA) expression
was analyzed at 3, 6, 16, and 24hours post scratch wounding (SW) of a HaCaT monolayer. Zero represents unwounded cells. (b) C/EBPg protein expression,
assessed by western blotting, was analyzed at 3, 6, 16, and 24 hours post SW. Upper panel: representative blot; lower panel: densitometric analysis. Four
independent experiments were conducted. (c) C/EBPa mRNA expression at 3, 6, 16, and 24 hours post SW. *Po0.05 versus unwounded cells. Six independent
experiments were conducted. (d) C/EBPa protein expression at 3, 6, 16, and 24hours post SW. Upper panel: representative blot; lower panel: densitometric
analysis of four independent experiments.
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suppressed to B51% (Supplementary Figure S1 online). We
found that C/EBPg silencing significantly impaired cell
migration to both EGF and 20% FBS (Figure 3a and b). As
an independent way to assess the role of C/EBPg in cell
migration, the migratory response of C/EBPg-overexpressing
cells to EGF and to serum was evaluated. In these
experiments, we transiently transfected HEK/293 cells,
because of poor transfectability of HaCaT cells. In keeping
with the results obtained from C/EBPg shRNA experiments,
C/EBPg overexpression induced a statistically significant
positive effect on cell migration to both EGF (both at 10 and
50ngml1) and 20% FBS in a Boyden chamber assay (Figure
3c and d). To assess whether EGFR signaling would have a
role in the C/EBPg overexpression–induced cell migration to
serum (Figure 3d), we performed an additional set of experi-
ments in the presence or absence of the EGFR inhibitor PD168393
(2 mM), and found that such molecule abrogated C/EBPg
overexpression–induced migration to 20% FBS (Figure 3e). As
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Figure 3. CAAT enhancer–binding protein c (C/EBPc) promotes cell migration to EGF and to 20% fetal bovine serum (FBS) via EGFR. C/EBPg-silenced
HaCaT cells were tested for migration to (a) 10–100 ngml1 EGF and (b) to 20% FBS. Further, the migration of C/EBPg-overexpressing versus control HEK/293
cells to (c) 10–50 ngml1 EGF and (d) to 20% FBS was evaluated. Three to five experiments were conducted. *Po0.05 between CTRL- and C/EBPg-engineered
cells. (e) Shown is the effect of the EGFR inhibitor PD168393 (2 mM) on C/EBPg overexpression–induced migration to 20% FBS. As an internal control for
the efficacy of the inhibitor, PD168393 was tested on EGF-induced migration (50 ngml1; f). *Po0.05.
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a control, we evaluated the efficacy of PD168393 on EGF-
induced migration (Figure 3f).
C/EBPc silencing impairs EGF-induced cell proliferation
Further, although C/EBPg silencing did not affect keratinocyte
proliferation and DNA synthesis, as assessed by cell count
and 5-bromo-2-deoxyuridine incorporation, respectively
(Figure 4a and b), it inhibited EGF-induced proliferation in
HaCaT cells at 48 hours (Figure 4c).
C/EBPc silencing impairs wound closure in vivo
We next investigated whether C/EBPg may affect wound
closure in vivo. Excisional wounds were performed on the
back of CD1 mice by punch biopsy (3.5mm diameters), and
control or C/EBPg siRNAs were applied directly into the
wounds at 0, 3, and 5 days after wounding. Digital pictures
were taken at the time of wounding (t0) and 3, 5, 7, 10, and 14
days post wounding. A representative experiment is shown in
Figure 5a. C/EBPg silencing in vivo (Supplementary Figure S2
online) showed a wound closure impairment (Figure 5b)
compared with controls at days 3, 5, 7, and 14 post wounding
(Po0.05). The average of three independent experiments is
shown. Further, the extent of the epithelial gap and granulation
tissue formation on central sections of wounds of C/EBPg-
silenced versus control mice has been assessed at day 3 and 5
post excision. An increase of the epithelial gap, i.e., the
distance between migrating edges of keratinocytes, was
observed both at day 3 (0.48±0.14 vs. 0.99±0.19, Po0.05)
and day 5 (0.08±0.05 vs. 0.57±0.20, P¼0.01) post
wounding (Figure 5c); thus, C/EBPg silencing inhibited re-
epithelialization in vivo. On the contrary, a decrease in the
area of granulation tissue was observed in siRNA C/EBPg–-
treated mice compared with siRNA control–treated mice,
following hematoxylin and eosin staining at both day 3
(0.35±0.03 vs. 0.25±0.04mm2, Po0.05) and day 5
(0.45±0.05 vs. 0.29±0.04mm2, Po0.01; Figure 5d). Further,
siRNA C/EBPg- versus siRNA control–treated mice showed a
decreased number of arterioles per mm2, i.e., 9.5±1.7
versus 5.3±0.9, Po0.05, respectively, at day 5 post wound-
ing, as assessed by a-actin staining (Figure 5e,f). These data are
in keeping with a role of C/EBPg in promoting wound closure.
C/EBPc impairs scratch wound–induced EGFR and paxillin
phosphorylation
EGF receptor signaling is a major factor in the WH process
(Schneider et al., 2008). We therefore assessed whether C/
EBPg may affect activation of EGFR following SW. EGFR
Y1068 and Y1173 are tyrosine residues phosphorylated upon
wounding (Kioka et al., 2010). In shRNA control–infected
cells, EGFR Y1068 phosphorylation significantly increased at
2 hours post wounding, differently from C/EBPg-silenced
cells, in which no statistically significant increase of EGFR
Y1068 phosphorylation was observed (Figure 6a upper and
lower panel). Further, we found that C/EBPg silencing also
impaired scratch-induced Y1173 EGF receptor phosphoryla-
tion at 6 hours post wounding (Figure 6b).
Paxillin is a key component of focal adhesions and is
phosphorylated upon EGFR signaling (Richardson et al.,
1997). We here showed that C/EBPg silencing impaired
scratch wound–induced Y118 paxillin phosphorylation at
0.5 hours post SW (Figure 6c).
Interestingly, C/EBPg mRNA (Supplementary Figure S3a
online) and protein (Supplementary Figure S3b online)
expression was increased by treatment of HaCaT cells with
100 ngml1 EGF for 16–24 hours and for 24 hours, respec-
tively, further supporting a regulatory loop between C/EBPg-
and EGF-induced signaling.
DISCUSSION
Transcription factors are key and fine-tuners of biological
processes, including epidermal WH. It is noteworthy that
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Figure 4. CAAT enhancer–binding protein c (C/EBPc) silencing impairs EGF-
induced cell proliferation. (a, b) Cell proliferation of C/EBPg-silenced HaCaT,
as assessed by both cell count and BrdU incorporation, respectively. (c) Cell
proliferation of C/EBPg-silenced versus control cells in response to EGF
treatment for 24–48hours, as assessed by cell count. Three independent
experiments were conducted. *Po0.05.
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c-jun has been previously demonstrated to have an important
role in wound repair in vivo, in keratinocyte migration, and in
EGF receptor activation at the leading edge of wounds (Li
et al., 2003). Further, c-fos is a epidermal wound response
gene in Drosophila (Pearson et al., 2009).
In this study, we aimed at identifying transcription factors
accelerating or inhibiting wound repair as putative therapeu-
tic tools in chronic skin ulcer treatment. Among the 42 factors
tested, we found that, although C/EBPg, STAT3, REL, RELA,
RELB, SP1, and NFkB silencing impaired skin WH in vitro,
CEBBP and E2F1 silencing accelerated wound repair.
Although NFkB is known to protect keratinocytes from
premature apoptosis during cell migration and differentiation
(Weisfelner and Gottlieb, 2003) and NFkB subunits were
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Figure 5. CAAT enhancer–binding protein c (C/EBPc) silencing impairs in vivo wound closure. The effect of C/EBPg or control small interfering RNA (siRNA)
on wound closure following excisional wounds in CD1 mice was tested. Digital pictures were taken at t0, 3, 5, 7, 10, and 14 days post scratch wounding (SW).
(a) Representative experiment (bar¼5mm). (b) Average results of percentage wound closure of siRNA C/EBPg compared with siRNA CTRL–treated
mice. Each time point represents the mean of the results obtained in 10–31 mice. (c) Effect of gene silencing on epithelial gap (mm) assessed at days 3 and 5 post
SW. (d) Granulation tissue area at days 3 and 5. (e) The histogram shows arteriole number per mm2 at day 5. Shown is the mean±SD of three independent
experiments. (f) Representative pictures of arterioles in siRNA CTRL (left) and siRNA C/EBPg–treated wounds (right), bar¼ 25 mm. *Po0.05.
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previously reported to induce, when silenced, epidermal
hyperplasia (Bell et al., 2003), no effect of NFkB and NFkB
family members has yet been reported, specifically, on wound
repair. Our data, therefore, can set the basis for further studies
on the role of such molecules on skin WH. Interestingly, the
results that we obtained by silencing STAT3, in the scratch
wound assay, are in keeping with that described by Sano et al.
(1999); on the contrary, the effect of E2F silencing, which
favored wound repair, is in contrast to that reported by
D’Souza et al. (2002) possibly because of different experi-
mental conditions.
We focused the present study on the role of the
transcription factor C/EBPg in skin WH, as its silencing
showed the maximal effect in epidermal wound closure
among the transcription factors tested.
C/EBPs are members of the basic leucine zipper class
of transcription factors. They contain a C-terminal basic
DNA-binding domain and a leucine zipper domain
involved in homodimerization or heterodimerization (Ramji
and Foka, 2002); their N-terminal region contains transcrip-
tion activation and regulatory domains for interaction
with basal transcription apparatus and transcription co-
activators. C/EBP family members have important roles in
cell proliferation, apoptosis, differentiation, in energy
metabolism, and in processes such as inflammation and
senescence (Ramji and Foka, 2002; Johnson, 2005). C/EBP a
and b were previously shown to be upregulated, as
keratinocytes undergo terminal differentiation (Lopez
et al., 2009). Further, C/EBPa and b knockout mice in the
epidermis showed increased proliferation of basal keratino-
cytes and impaired differentiation throughout the skin
layers (Lopez et al., 2009). Moreover, C/EBPb regulates
IL-6 production in wounded epidermis (Sugawara et al.,
2001).
C/EBPg is, instead, a poorly characterized member of the
C/EBP family, which can bind to mEBP-E-binding sites of the
IgH enhancer. Further, it can bind to regulatory elements of
G-CSF and IL-4 (Nishizawa et al., 1991; Davydov et al.,
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1995) and promote the expression of the DNA repair
molecule ERCC5 (Crawford et al., 2007).
It lacks N-terminal transcription activation domains, but it
is able to interact, via leucine zipper domains, with other
transcription factors, regulating their activity. In fact, it hetero-
dimerizes with other C/EBP proteins and with ATF family
members (Nerlov, 2008). C/EBPg knockout mice were found
to die within 48hours after birth and showed an impaired func-
tional maturation of natural killer cells (Kaisho et al., 1999).
The role of C/EBP family members in wound repair is
poorly characterized. In the present study, we found that
C/EBPg regulates WH. Specifically, we obtained evidence
that C/EBPg silencing impaired wound closure both in vitro
and in vivo. We here showed that C/EBPg silencing inhibited
(a) SW, (b) cell migration to both serum and EGF, and
(c) EGF-induced proliferation in HaCaT, whereas C/EBPg
overexpression increased cell migration to EGF, and to serum
via EGFR.
Further, C/EBPg silencing impaired WH in vivo at 3, 5, 7,
and 14 days following excisional wounding in mice,
inhibited re-epithelialization and granulation tissue forma-
tion, and decreased arteriole number.
Wound epithelialization, which depends on keratinocyte
migration, proliferation, and differentiation, is one of the
crucial steps in WH (Kim et al., 2001). One of the major
regulator of epidermal WH is EGF, which, via signaling
through a tyrosine kinase receptor, promotes keratinocyte
migration, fibroblast function, and granulation tissue
formation (Pastore et al., 2008). A number of factors,
including c-jun (Li et al., 2003), angiotensin II (Yahata
et al., 2006), and tissue kallikrein (Gao et al., 2010), affect
wound repair by regulating EGF receptor signaling. In the
present study, we found that C/EBPg silencing impaired
WH in vitro, at least in part, via a decrease of Y1068 and
Y1173 EGFR phosphorylation. Moreover, we have shown that
C/EBPg overexpression induces an increase of cell migration to
20% FCS via EGFR, as demonstrated by a specific EGFR
inhibitor.
Focal adhesions are actin–integrin links that allow cell
attachment to extracellular matrix and have a major role in
orchestrating cell migration, following the generation of
mechanical forces, which is a key process involved in wound
repair. Several proteins are organized in protein complexes
via binding of a number of molecules including talin,
vinculin, and focal adhesion kinases to integrins.
Paxillin is a focal adhesion adaptor protein that has a
pivotal role in adhesion- and growth factor–induced signaling
at the plasma membrane. It interacts with a number of
proteins, such as vinculin, via structural domains, and via
specific tyrosine and serine residues (Turner, 2000; Schaller,
2001). In the present study, we found that C/EBPg silencing
impaired scratch wound–induced Y118 paxillin phosphoryla-
tion. As both EGF receptor and paxillin phosphorylation have
a role in cell migration, we hypothesize that C/EBPg promotes
epithelial cell migration, at least in part, by inducing EGFR
and paxillin phosphorylation.
The mechanisms through which C/EBPg regulates tran-
scription are poorly understood (Cooper et al., 1995; Nerlov,
2008). Further studies are needed to address this issue, in the
context of the wound repair process, which may lead to the
identification of biological effectors of C/EBPg.
MATERIALS AND METHODS
Cell culture, transfection, and reagents
HaCaT keratinocytes were grown in DMEM containing 10% FBS, for
a maximum of nine passages. HEK/293 cells were grown in MEM
containing 10% FBS and transfected, at 70% confluency, with Lipo-
fectamine Plus (Invitrogen, Carlsbad, CA) according to the manu-
facturer’s instructions. EGF was purchased from Sigma (St Louis, MO).
Screening
The transcription factor siRNA array (SureSilencing) was purchased
from SABiosciences (http//:www.sabiosciences.com). It contains
duplicate wells of siRNA pairs that target 42 different transcription
factors, plus four duplicates siRNA control wells. The following
transcription factors were silenced: AR, ATF1, ATF2, ATF3, C/EBPB,
C/EBPG, CREB1, CREBBP, CTNNB1, E2F1, ELK1, FOS, FOXA2,
HAND1, HDAC1, HIF1A, HSF1, ID1, JUND, MEF2A, MYC, NFAT5,
NFATC1, NFATC3, NFKB1, NFKB2, PPARA, RB1, REL, RELA, RELB,
SMAD2, SMAD3, SMAD4, SMAD9, SP1, STAT3, STAT5A, STAT5B,
TBP, TP53, and YY1. Cells were reverse-transfected according to the
manufacturer’s instructions. Briefly, Opti-MEM medium (Invitrogen)
and transfection reagent SureFECT (SABiosciences) were added to
resuspend the siRNAs, and then 104 cells were added to each well
for reverse transfection with siRNAs. After 24 hours, the medium was
replaced and the SW assay was performed using a yellow tip (see
below). Immediately after wounding (t0), cells were washed once
with growth medium and incubated for further 24 hours (t24). Digital
pictures were taken with an Axiovert ZEISS microscope (Milan,
Italy), at both t0 and t24. Area closure was measured by using the
Image J program (NIH, Bethesda, MD). Area closure of each well
was measured as the ratio of the area at t24 divided by the area at
time t0. All values were normalized to the mean of siRNA control
wells, whose value was set at 1.
shRNA infections
To have an independent assessment of the role of selected genes in
wound repair, pLKO.1 puro-based lentiviral shRNA vectors (Sigma)
were used to downregulate C/EBPg and NFkB genes. See Supple-
mentary data online, Materials and Methods sections for details.
In vitro scratch assay
C/EBPg- and NFkB-silenced cells, as well as control cells, were
cultured to confluence on 96-well plates; the medium was replaced
before inducing a linear scratch. Detached cells were removed by
washing and area closure was analyzed as described above. For
immunoblotting, cells were cultured on 35-mm plates, and four lines
were generated by scratching. Cells were then lysed with radio-
immuno precipitation assay buffer followed by SDS–polyacrylamide
gel electrophoresis. Unwounded cells were used as controls.
mRNA expression
Total RNA was converted to complementary DNA by reverse trans-
cription (Superscript Preamplification System, Invitrogen), according
to the manufacturer’s instructions. mRNA expression levels were
calculated by Comparative cT Method (Applied Biosystem,
www.jidonline.org 1915
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Carlsbad, CA) and as previously described (Melchionna et al., 2010).
Primers for human C/EBPg, glyceraldehyde-3-phosphate dehydro-
genase (GAPDH), C/EBPa, and NFkB genes are shown in Supple-
mentary data online, Materials and Methods section. Normalization
was performed using GAPDH primers, and mRNA expression levels
were determined by the-2DDCt method.
Immunoblotting
Cells were scratch-wounded for the indicated time points in serum-
free medium to determine protein expression of C/EBPg, C/EBPa,
EGFR, paxillin, pEGFR, and ppaxillin. Details of WB are included in
the Supplementary data online, Materials and Methods section.
In vivo WH
CD1 male mice, 8 weeks of age, were anesthetized with
100mg kg1 ketamine and 1mg kg1 acepromazine. Their dorsum
was clipped free of hair and a full-thickness wound of 3.5mm
diameter was created using a biopsy punch (Straino et al., 2008).
Control or C/EBPg siRNAs (10 nM), together with the siPORT
NeoFX transfection reagent (Applied Biosystems), were applied
directly into the wounds at 0, 3, and 5 days after wounding. Digital
pictures were taken at the time of wounding (t0) and 3, 5, 7, 10, and
14 days post wounding to evaluate percentage wound closure (mice:
n¼ 10–31). Wound areas were calculated by using the IAS 2000
DELTA-SISTEMI software (Rome, Italy). For each sample, the
percentage of wound closure was measured as a ratio of the area,
at each time point, divided by the area at t0 (i.e., immediately after
wounding). The average of three independent experiments is shown.
See Supplementary data online, Materials and Methods section. For
histology and immunohistochemical analysis see Supplementary
data online.
Migration assay
Chemotaxis was evaluated in 48-well Boyden’s chambers as
previously described (Melchionna et al., 2010). Briefly, cells were
resuspended at 0.5 106 cellsml1 in migration medium: Roswell’s
Park Memorial Institute, 25mM 4-(2-hydroxyethyl)-1-piperazineetha-
nesulfonic acid, 0.01% BSA, and incubated for 5 hours at 371C on
8-mM pore size, collagen IV–coated polycarbonate filters (Costar,
Cambridge, MA). After staining with Diff-Quick (DADE, Dudingen,
Switzerland), the number of migrating cells was determined by
counting six random fields at  40 magnification. The migration
index was calculated by dividing the number of cells migrated in the
presence of 20% FBS, or 10–100 ngml1 EGF, by the number of cells
migrated in migration medium alone. In a set of experiments,
migration to 20% FBS was evaluated in the presence or absence of
the EGFR inhibitor PD168393 (2mM).
Proliferation assay
A total of 104 C/EBPg-silenced and control cells were plated in 12
wells/plates and grown in complete medium. At the indicated times
points the cells were washed and fixed. After staining with Diff-
Quick, the number of cells was determined by counting six random
fields. In a different set of experiments, C/EBPg-silenced and control
cells were grown in DMEM without serum and treated with
20 ngml1 EGF for 24 and 48 hours, and at such time points cells
were counted. For 5-bromo-2-deoxyuridine methods (Di Carlo et al.,
2004), see Supplementary data online.
Statistical analysis
Data are expressed as mean±SD, or SE Student’s two-tailed t-test or
analysis of variance was performed, when appropriate, and P-value
o0.05 was considered statistically significant.
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